Dr. Thomas Bird

Dr Thomas Bird is a Consultant Clinical Oncologist at the Bristol Cancer Institute, specialising in upper gastro-intestinal, pancreatic and urological cancers. He also has a specialist interest in stereotactic radiotherapy (SABR) for cancer that has spread to a limited number of sites (oligometastatic disease) and stereotactic radiotherapy for localised prostate cancer.

Before taking up his Consultant post in Bristol, Dr Bird completed his medical training in Edinburgh and Specialist Training in Oncology at the Royal Marsden Hospital, Guy's Hospital and the Kent Oncology Centre. He was awarded a Masters degree in Oncology with distinction from the Institute of Cancer Research (University of London) for research evaluating the effectiveness of intensity-modulated radiotherapy (IMRT) and PET-CT imaging to reduce treatment side effects for patients. He completed a 12-month Radiotherapy Fellowship at the Peter MacCallum Cancer Centre (Melbourne, Australia) and published on outcomes with combination chemotherapy and radiotherapy treatments, as well as the use of complex pelvic radiotherapy approaches for recurrent cancer.

Dr Bird is keenly involved with research and actively recruits and manages patients enrolled in clinical trials. He has several first name publications in peer-reviewed journals and has presented at both national and international conferences.

Diseases, Medical Tests and Treatments

• Stereotactic radiotherapy
• Chemotherapy
• Radiotherapy
• Image-Guided Radiotherapy (IGRT)
• Intensity Modulated Radiotherapy (IMRT)
• Bladder Cancer
• Gastro-Intestinal Cancers
• Genitourinary Cancer
• Oesophageal Cancer
• Pancreatic Cancer
• Prostate Cancer
• Renal (Kidney) Cancer
• Stomach Cancer